Wellington Management Group
NTGN

Wellington Management Group’s Neon Therapeutics, Inc. Common Stock NTGN Stock Holding History

Wellington Management Group’s Portfolio NTGN Stock Details NTGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-1,495,218
Closed -$7.09M – 2169
2019
Q2 		$7.09M Sell
1,495,218
-79,767
-5% -$447K ﹤0.01% 1295
2019
Q1 		$10.2M Sell
1,574,985
-659,771
-30% -$3.45M ﹤0.01% 1201
2018
Q4 		$11.2M Sell
2,234,756
-240,351
-10% -$1.68M ﹤0.01% 1155
2018
Q3 		$21.1M Buy
2,475,107
+88,548
+4% +$981K ﹤0.01% 1069
2018
Q2 		$30M Buy
+2,386,559
New +$32.7M 0.01% 951

Other funds holding NTGN

TGI
TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HMC
Harvard Management Company Boston, Massachusetts $1.82B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
ECM
Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wellington Management Group's NTGN Position: Q3 2019 in Review

Wellington Management Group sold out of Neon Therapeutics, Inc. Common Stock (NTGN) in Q3 2019, closing a stake of 1,495,218 shares — an estimated $7.09M sold.

Wellington Management Group first reported a position in NTGN in Q2 2018 and held it in 5 quarters. The position peaked at $30M in Q2 2018. 58 funds tracked by Wall St. Rank hold NTGN as of Q3 2019.

  • Wellington Management Group reported no remaining Neon Therapeutics, Inc. Common Stock position as of Q3 2019 after selling out during the quarter.
  • Wellington Management Group sold 1,495,218 Neon Therapeutics, Inc. Common Stock shares in Q3 2019, an estimated $7.09M.
  • Wellington Management Group first reported a position in Neon Therapeutics, Inc. Common Stock in Q2 2018 and held it in 5 quarters.
  • Wellington Management Group's Neon Therapeutics, Inc. Common Stock position peaked at $30M in Q2 2018.
  • 58 funds tracked by Wall St. Rank held Neon Therapeutics, Inc. Common Stock as of Q3 2019.

Based on Wellington Management Group's 13F filing for Q3 2019, filed 13 Nov 2019.